Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome
Clinical trial NCT01243476 · COMPLETED
Trial details
- NCT number
- NCT01243476
- Sponsor
- Fundación General de la Universidad de Salamanca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2022-06-06
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.